People in Nashville who love their cats despite being allergic to them can participate in a clinical trial for a new treatment option.

Written by

Nashville-based BreatheAmerica is seeking participants for a clinical trial of an experimental drug for cat allergies. It's a monthly immunotherapy treatment, called Cat-PAD, that involves injecting a liquid under the top layer of the cat owner's skin, where the substance dissolves.

The clinical trial is a Phase 3 study, which means the medicine has already been tested for safety and that researchers seek to measure its effectiveness on a larger group of people. ...